NEW YORK (GenomeWeb News) – The Allen Institute for Brain Science will perform in situ hybridization services on tissues for the ALS Therapy Development Institute (ALS TDI) to help identify cells linked to gene expression with the hope of developing treatments for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, ALS TDI said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.